0.24 USD
↗ 0.00 (1.57%)AT CLOSE (03:59 PM EDT)
Context Therapeutics Inc. Common Stock
CNTXNASDAQ • USD
0.24
↘ 0.00 (0.96%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
0.24
↘ 0.00 (0.96%)
Market: CLOSED
CNTX is currently priced at $0.24. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 23, 2026.
Open?$0.23
High?$0.24
Low?$0.22
Prev. Close?$0.24
Volume?1.5M
Avg. Volume?1.1M
VWAP?$0.24
Rel. Volume?1.31x
Bid / Ask
Bid?$0.23 × 200
Ask?$0.24 × 22.7K
Spread?$0.01
Midpoint?$0.24
Valuation & Ratios
Market Cap?22.1M
Shares Out?N/A
Float?69.3M
Float %?75.4%
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$0.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Themes
Employees
15
Market Cap
22.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
PHILADELPHIA, PA 19103
Phone: 267-225-7416
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?79
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.51Distress
Confidence?43%Low
Short InterestElevated
Short % of Float?6.79%Elevated
Short Interest?4.7M
Days to Cover?4.0
Free Float69.3M
Avg Daily Volume1.2M
Settlement Date2026-09-30
Financial Health
Current Ratio?5.81Strong
Quick Ratio?5.81Strong
Cash Ratio?5.45Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.58CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-120.4%WEAK▾
S&P3
ROA?-99.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-34026676
Enterprise Value?$-20939369
Fundamentals ratios updated end of day